Turnstone Biologics Corp.
TSBX
$0.35
$0.0319.72%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 24.42% | 20.05% | -8.53% | -19.33% | 5.02% |
| Total Depreciation and Amortization | -31.36% | -1.41% | -2.16% | -22.76% | -5.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.63% | -24.60% | 73.61% | 278.95% | -95.35% |
| Change in Net Operating Assets | -203.82% | -132.25% | 219.31% | 550.24% | 105.55% |
| Cash from Operations | 6.26% | -10.37% | 8.79% | -12.62% | 17.47% |
| Capital Expenditure | 1,800.00% | 100.95% | 27.08% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | 2,192.31% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.37% | 27.49% | 33.58% | 355.32% | 86.72% |
| Cash from Investing | -12.29% | 28.03% | 34.38% | 365.69% | 87.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 164.13% | -- | -- | -100.00% |
| Cash from Financing | -100.00% | 222.92% | -- | -- | -100.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.80% | 126.82% | 188.20% | 83.96% | -221.64% |